Indeed, within the tumor microenvironment, IL-6 secreted by TNBC cells upregulates CCL5 expression in lymphatic endothelial cells by activating the IL-6 receptor, STAT3, which subsequently enhances transcription of the CCL5 gene. The gene discussed is STAT3; the disease is neoplasm.